This is a StreetInsider.com Premium Only Page

Castle Biosciences Inc. (CSTL) –

Apr 16, 2024 04:47 PM Form 4 CASTLE BIOSCIENCES INC For: Apr 12 Filed by: MAETZOLD DEREK J

Apr 12, 2024 04:37 PM Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J

Apr 11, 2024 07:00 AM Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Apr 10, 2024 05:00 PM Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

Apr 10, 2024 04:35 PM Form 4 CASTLE BIOSCIENCES INC For: Apr 08 Filed by: BRADBURY DANIEL

Apr 10, 2024 04:09 PM Form ARS CASTLE BIOSCIENCES INC For: Apr 10

Apr 10, 2024 04:08 PM Form DEFA14A CASTLE BIOSCIENCES INC

Apr 10, 2024 04:07 PM Form DEF 14A CASTLE BIOSCIENCES INC For: Apr 10

Apr 10, 2024 07:00 AM Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

Apr 8, 2024 04:32 PM Form 4 CASTLE BIOSCIENCES INC For: Apr 04 Filed by: BRADBURY DANIEL

Apr 5, 2024 04:38 PM Form 4 CASTLE BIOSCIENCES INC For: Apr 03 Filed by: MAETZOLD DEREK J

Apr 4, 2024 05:02 PM Form 144 CASTLE BIOSCIENCES INC Filed by: BRADBURY DANIEL

Apr 4, 2024 04:30 PM Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer

Apr 2, 2024 07:00 AM Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 28, 2024 04:45 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 26 Filed by: Cotton Rodney

Mar 28, 2024 04:35 PM Form 3 CASTLE BIOSCIENCES INC For: Mar 26 Filed by: Cotton Rodney

Mar 27, 2024 05:05 PM Form 8-K CASTLE BIOSCIENCES INC For: Mar 26

Mar 27, 2024 05:01 PM Castle Biosciences (CSTL) Appoints Rodney Cotton to its Board

Mar 27, 2024 05:00 PM Castle Biosciences Announces Updates to its Board of Directors

Mar 25, 2024 07:00 AM Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Mar 22, 2024 05:17 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 20 Filed by: MAETZOLD DEREK J

Mar 22, 2024 04:30 PM Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide

Mar 19, 2024 07:00 AM Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Ther

Mar 15, 2024 04:30 PM New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Al

Mar 12, 2024 07:00 AM Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Mar 11, 2024 05:19 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 07 Filed by: MAETZOLD DEREK J

Mar 8, 2024 04:30 PM Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Mar 7, 2024 05:15 PM Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J

Mar 7, 2024 07:03 AM Castle Biosciences (CSTL) Reports New Data Confirming DecisionDx-SCC Provides Significant and Clinically Actionable Risk-Stratification of Patients

Mar 7, 2024 07:00 AM In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups

Mar 6, 2024 06:08 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Juvenal Tobin W

Mar 6, 2024 06:04 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Oelschlager Kristen M

Mar 6, 2024 06:01 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Stokes Frank

Mar 6, 2024 05:58 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: MAETZOLD DEREK J

Mar 6, 2024 05:53 PM Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: BRADBURY DANIEL

Mar 5, 2024 07:14 PM Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J

Mar 1, 2024 07:06 AM Castle Biosciences (CSTL) PT Raised to $37 at Scotiabank

Mar 1, 2024 05:22 AM Castle Biosciences (CSTL) PT Raised to $28 at KeyBanc

Feb 29, 2024 06:54 AM Castle Biosciences (CSTL) PT Raised to $33 at Baird

Feb 28, 2024 05:27 PM Castle Biosciences (CSTL) Files $300M Mixed Shelf

Feb 28, 2024 05:27 PM Form S-8 CASTLE BIOSCIENCES INC

Feb 28, 2024 05:26 PM Form S-3 CASTLE BIOSCIENCES INC

Feb 28, 2024 04:21 PM Castle Biosciences Inc. (CSTL) Tops Q4 EPS by 48c ; Offers Guidance

Feb 28, 2024 04:13 PM Form 8-K CASTLE BIOSCIENCES INC For: Feb 28

Feb 28, 2024 04:13 PM Form 10-K CASTLE BIOSCIENCES INC For: Dec 31

Feb 28, 2024 04:05 PM Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results

Feb 26, 2024 07:01 AM Castle Biosciences Inc. (CSTL) Announces Study Finds DecisionDx-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma

Feb 26, 2024 07:00 AM Study Finds DecisionDx®-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging

Feb 14, 2024 09:00 AM Form SC 13G CASTLE BIOSCIENCES INC Filed by: Granahan Investment Management, LLC

Feb 13, 2024 06:09 PM Form SC 13G/A CASTLE BIOSCIENCES INC Filed by: VANGUARD GROUP INC